Innate Pharma S.A. (IPHA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 133.18M |
| Enterprise Value | 127.66M |
| P/E Ratio | -2.72 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 148.58 |
| Price/Book Ratio | -3.21 |
| Enterprise/Revenue | 161.77 |
| Enterprise/EBITDA | -3.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -45.54 |
| Operating Margin | -51.33 |
AD
Management Effectiveness
| Return On Assets | -1.37 |
| Return On Equity | 1.53 |
Income Statement
| Revenue | 2.79M |
| Revenue/Share | 0.01 |
| Gross Profit | 2.79M |
| EBITDA | -43.65M |
| Net Income | -49.18M |
| Diluted EPS | -0.53 |
Balance Sheet
| Total Cash | 10.89M |
| Total Cash/Share | 0.12 |
| Total Debt | 20.2M |
| Total Debt/Equity | -0.5 |
| Current Ratio | 0.6 |
| Book Value Per Share | -0.43 |
Price History
| 52-Week Change | -25.7 |
| 52-Week High | 2.71 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 1.66 |
| Moving Average 200 Days | 1.7 |
Statistics
| Average Volume | 47,675 |
| Shares Outstanding | 108.42M |
| % Held by Institutions | 0.22 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
